Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024

Core Viewpoint - Affimed N.V. is set to release its first quarter 2024 results and corporate update on June 12, 2024, with a conference call scheduled for 8:30 a.m. EDT / 14:30 CET [1]. Company Overview - Affimed N.V. is a clinical-stage immuno-oncology company focused on harnessing the innate immune system to combat cancer, utilizing its proprietary ROCK® platform to develop innate cell engagers (ICE®) that target and kill various tumors [3]. - The company is headquartered in Mannheim, Germany, and is led by a team of experienced biotechnology and pharmaceutical professionals dedicated to improving cancer treatment outcomes [3]. Conference Call Details - The conference call will be accessible via phone and webcast, with a live audio webcast available on the company's investor relations page [1]. - Participants are encouraged to join the call 15 minutes early to avoid delays, and a replay of the webcast will be available for 30 days post-call [2].